A high-level overview of Amphastar Pharmaceuticals, Inc. (AMPH) stock. View (AMPH) real-time stock price, chart, news, analysis, analyst reviews and more.

Scientists have developed a nasal "molecular shield" that disarms pollen, blocking allergic reactions fast without the use of ...

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...

People with rhinitis or sinusitis or who have chronic congestion are invited to join this 30-minute study, which is testing a novel way to decongest the nose without any medication or invasive procedu ...

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...

Premature babies often need help breathing as their lungs are not fully developed. Nasal breathing support (through the nose) helps premature babies breathe without the need for breathing tubes in the ...

The companies are also running an open-label study to evaluate the long-term efficacy and safety of the therapy.